| Literature DB >> 28991049 |
Wenbo Li1,2, Wei Zhang3,4, Meihong Deng2, Patricia Loughran5, Yiting Tang6, Hong Liao2, Xianying Zhang7, Jian Liu7, Timothy R Billiar1,2, Ben Lu6,7.
Abstract
Stearoyl lysophosphatidylcholine (LPC) exerts protective effect during endotoxemia and in experimental sepsis, but the underlying mechanism is unclear. Here, we demonstrated that stearoyl LPC could block caspase-11-mediated macrophage pyroptosis. In vitro, stearoyl LPC significantly decreased caspase-11 activation and pyroptosis induced by lipopolysaccharide (LPS) plus cholera toxin subunit B independent of the receptor G2A. Stearoyl LPC did not affect LPS uptake by mouse peritoneal macrophages but did significantly inhibit the interaction between LPS and caspase-11. Moreover, stearoyl LPC treatment conferred significant protection against lethal endotoxemia and significantly reduced the release of IL-1α and IL-1β. These findings identify stearoyl LPC as an inhibitor of LPS-mediated caspase-11 activation. This mechanism could explain the protective action of stearoyl LPC in experimental sepsis and endotoxemia.Entities:
Mesh:
Substances:
Year: 2018 PMID: 28991049 PMCID: PMC5882614 DOI: 10.1097/SHK.0000000000001012
Source DB: PubMed Journal: Shock ISSN: 1073-2322 Impact factor: 3.454